0001104659-22-020844.txt : 20220211
0001104659-22-020844.hdr.sgml : 20220211
20220211202330
ACCESSION NUMBER: 0001104659-22-020844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220209
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siddiqui Khan
CENTRAL INDEX KEY: 0001898560
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39949
FILM NUMBER: 22624034
MAIL ADDRESS:
STREET 1: 530 OLD WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hyperfine, Inc.
CENTRAL INDEX KEY: 0001833769
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
BUSINESS PHONE: 866-796-6767
MAIL ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
FORMER COMPANY:
FORMER CONFORMED NAME: HealthCor Catalio Acquisition Corp.
DATE OF NAME CHANGE: 20201124
4
1
tm226447-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-09
0
0001833769
Hyperfine, Inc.
HYPR
0001898560
Siddiqui Khan
C/O HYPERFINE, INC.
351 NEW WHITFIELD STREET
GUILFORD
CT
06437
0
1
0
0
Chief Medical Officer and CSO
Stock Option (right to buy)
3.90
2022-02-09
4
A
0
110000
0.00
A
2032-02-09
Class A Common Stock
110000
110000
D
Stock Option (right to buy)
3.90
2022-02-09
4
A
0
74000
0.00
A
2032-02-09
Class A Common Stock
74000
74000
D
The shares underlying this option vest as to 25% on the date of grant, and 2.083% at the end of each month thereafter beginning on February 31, 2022, subject to Dr. Siddiqui's continued service through the applicable vesting date; provided that any vesting of the award will be delayed if as of the applicable vesting date a registration statement on Form S-8 registering shares under the registrant's 2021 Equity Incentive Plan has not yet been filed with the Securities and Exchange Commission, and in such event the number of options vesting on the first scheduled vesting date following the filing of the registration statement will also include any delayed vesting options.
The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.
/s/ Neela Paykel, Attorney-in-Fact
2022-02-11